Oil Prices Edge Higher as Market Skepticism Grows Over USIran Diplomatic Progress April US Payrolls Surge Past Expectations Yet Underlying Red Flags Emerge Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Evolving Cybersecurity Demand Micron Milestone Dicks Earnings Paxton Defeats Cornyn Morning Market Roundup Wordle 1804 Release Highlights NYT Puzzle Appeal Venture Global Posts Strong Q1 2026 Results Raises FullYear EBITDA Guidance ST Bancorp Inc Q1 2026 Earnings Earnings Beat Driven by Strong Net Interest Margin MMYT Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Optimistic Travel Demand Outlook Annovis Bio Q1 2026 Earnings EPS Misses Estimates but Shares Rally on Pipeline Optimism WAVE Q1 2026 Earnings EPS Beats Estimates by Wide Margin Stock Declines International Money Express Inc IMXI Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Stock Slips ULH Q1 2026 Earnings Wide Earnings Miss as Company Posts Unexpected Loss Silexion Therapeutics Warrants SLXNW Hold Steady at 002 Amid Thin Trading Energy Recovery Inc ERII Rises 267 as It Approaches Key Resistance at 929 Iveda Solutions Warrant IVDAW Holds Steady at 003 Amid Minimal Volatility Creative Medical Technology Holdings CELZ Slips 13 as Stock Tests Key Support at 217 Enhabit Inc EHAB Edges Higher Amid Tight Trading Range Benitec Biopharma BNTC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline Adagio Medical Holdings ADGM Q1 2026 Earnings WiderThanExpected Loss Highlights Ongoing Development Costs Phoenix New Media Q3 2024 Earnings WiderThanExpected Loss Amid Revenue Uncertainty MEOH Q1 2026 Earnings Earnings Miss on Weaker Methanol Pricing INMD Q1 2026 Earnings Earnings Miss as EPS Falls Short of Estimates nCino Inc NCNO Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Movement Microns AI Memory Demand Surge CEO Highlights 5066 Supply Gap as HBM Pricing Soars 51Talk Q3 2025 Earnings EPS Misses Amid Narrowing Revenue Visibility and Stock Decline Cabaletta Bio Holds Steady CABA Stock Rises Slightly Amid Biotech Volatility